tirzepatide vs semaglutide efficacy weight loss comparison Comparative and safety of 2.4 mg and 5–15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials Many pharmaceutical industry experts had

The once-weekly therapy achieved up to 10.7% weight loss over 42 weeks in adults with overweight or obesity, showing favorable tolerability compared to placebo

2016 May 6;34(5):458-61

This translates into a lower risk of chronic disease, better management of existing conditions, and ultimately, a longer, healthier lifespan

If you notice any changes in vision or eye problems while taking Rybelsus, speak with your doctor, as rapid improvements to your blood sugar can sometimes temporarily worsen diabetic eye disease

These include enhanced fat oxidation, improved insulin sensitivity through GIP-mediated pathways, and potentially greater preservation of lean mass during weight loss